Drug recall · May 28, 2014
Bystolic recall
Why: Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharmaceutica NV, Belgium, Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, NDC 0456-1420-30
- Lots / codes
Lot: A287945, Exp: 08/2015
- Quantity
- 21,875 bottles
- Company
- Forest Pharmaceuticals Inc, Earth City, MO
- Distribution
- Nationwide and Puerto Rico
- Initiated
- May 12, 2014 · Voluntary: Firm initiated
- Classified
- May 22, 2014
- Reported
- May 28, 2014
- Ended
- January 5, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bystolic
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.